Related Experiment Video

Updated: Oct 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines

I G Echániz-Avilés1, F Solórzano-Santos

  • 1Departamento de Epidemiología Clínica, Instituto Nacional de Salud Pública, Av. Universidad 655, Colonia Santa María Ahuacatitlán, 62508 Cuernavaca, Morelos, México. igechaniz@correo.insp.mx

Salud Publica De Mexico
|September 8, 2001
PubMed

Insights

Preventing pneumococcal disease in children with the 7-valent pneumococcal conjugate vaccine (PCV7) is crucial. Vaccination is safe, effective, and combats antibiotic-resistant Streptococcus pneumoniae strains, reducing disease burden and treatment costs.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health

Background:

  • Streptococcus pneumoniae causes significant pediatric invasive and noninvasive diseases globally.
  • Rising antibiotic-resistant strains complicate pneumococcal disease management.
  • Prevention through vaccination is a key public health strategy.

Purpose of the Study:

  • To evaluate the role of pneumococcal conjugate vaccines in preventing pediatric diseases.
  • To highlight the benefits of the 7-valent pneumococcal conjugate vaccine (PCV7).

Main Methods:

  • Clinical studies of pneumococcal conjugate vaccines in infants and children.
  • Review of approved vaccines for invasive disease prevention.

Main Results:

  • The 7-valent pneumococcal conjugate vaccine (PCV7; Prevnar/Prevenar) is approved and demonstrates safety and efficacy in infants and young children.
  • Routine PCV7 vaccination can prevent invasive pneumococcal disease.

Conclusions:

  • Routine vaccination with PCV7 offers a safe and effective method for preventing pneumococcal diseases in children.
  • Vaccination can mitigate the development of antibiotic-resistant Streptococcus pneumoniae strains.
  • Widespread vaccination can reduce disease management complexity and healthcare costs, especially in developing nations.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...